Heterocyclic compounds for cancer imaging and treatment and methods for their use
US10654811B2 · kind B2 · utility
11Cited by
28References
37Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 13, 2016 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Jan 13, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/088
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.